NHI Quote, Financials, Valuation and Earnings

SL Green Realty has a net margin of 50.43% compared to National Health Investors's net margin of 6.2%. National Health Investors's return on equity of 10.72% beat SL Green Realty's return on equity of 0.72%.

National Health Investors has a consensus price target of $82.00, signalling upside risk potential of 12.62%. On the other hand SL Green Realty has an analysts' consensus of $67.11 which suggests that it could grow by 35.22%. Given that SL Green Realty has higher upside potential than National Health Investors, analysts believe SL Green Realty is more attractive than National Health Investors.

National Health Investors has a beta of 0.788, which suggesting that the stock is 21.162% less volatile than S&P 500. In comparison SL Green Realty has a beta of 1.599, suggesting its more volatile than the S&P 500 by 59.918%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.94%. SL Green Realty offers a yield of 6.11% to investors and pays a quarterly dividend of $0.26 per share. National Health Investors pays 113.43% of its earnings as a dividend. SL Green Realty pays out 713.87% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than SL Green Realty quarterly revenues of $245.9M. National Health Investors's net income of $43.2M is higher than SL Green Realty's net income of $15.3M. Notably, National Health Investors's price-to-earnings ratio is 23.34x while SL Green Realty's PE ratio is 620.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.58x versus 3.82x for SL Green Realty. Usually stocks with elevated PS ratios are considered overvalued.

Simon Property Group has a net margin of 50.43% compared to National Health Investors's net margin of 42.22%. National Health Investors's return on equity of 10.72% beat Simon Property Group's return on equity of 66.01%.

National Health Investors has a consensus price target of $82.00, signalling upside risk potential of 12.62%. On the other hand Simon Property Group has an analysts' consensus of $188.08 which suggests that it could grow by 26.91%. Given that Simon Property Group has higher upside potential than National Health Investors, analysts believe Simon Property Group is more attractive than National Health Investors.

National Health Investors has a beta of 0.788, which suggesting that the stock is 21.162% less volatile than S&P 500. In comparison Simon Property Group has a beta of 1.453, suggesting its more volatile than the S&P 500 by 45.348%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.94%. Simon Property Group offers a yield of 5.57% to investors and pays a quarterly dividend of $2.10 per share. National Health Investors pays 113.43% of its earnings as a dividend. Simon Property Group pays out 128.47% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Simon Property Group quarterly revenues of $1.6B. National Health Investors's net income of $43.2M is lower than Simon Property Group's net income of $668.1M. Notably, National Health Investors's price-to-earnings ratio is 23.34x while Simon Property Group's PE ratio is 20.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.58x versus 8.10x for Simon Property Group. Usually stocks with elevated PS ratios are considered overvalued.

Ventas has a net margin of 50.43% compared to National Health Investors's net margin of 4.42%. National Health Investors's return on equity of 10.72% beat Ventas's return on equity of 0.81%.

National Health Investors has a consensus price target of $82.00, signalling upside risk potential of 12.62%. On the other hand Ventas has an analysts' consensus of $75.63 which suggests that it could grow by 14.4%. Given that Ventas has higher upside potential than National Health Investors, analysts believe Ventas is more attractive than National Health Investors.

National Health Investors has a beta of 0.788, which suggesting that the stock is 21.162% less volatile than S&P 500. In comparison Ventas has a beta of 1.017, suggesting its more volatile than the S&P 500 by 1.691%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.94%. Ventas offers a yield of 2.77% to investors and pays a quarterly dividend of $0.48 per share. National Health Investors pays 113.43% of its earnings as a dividend. Ventas pays out 912.26% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Ventas quarterly revenues of $1.3B. National Health Investors's net income of $43.2M is lower than Ventas's net income of $56.8M. Notably, National Health Investors's price-to-earnings ratio is 23.34x while Ventas's PE ratio is 347.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.58x versus 5.59x for Ventas. Usually stocks with elevated PS ratios are considered overvalued.

Welltower has a net margin of 50.43% compared to National Health Investors's net margin of 5.41%. National Health Investors's return on equity of 10.72% beat Welltower's return on equity of 3.21%.

National Health Investors has a consensus price target of $82.00, signalling upside risk potential of 12.62%. On the other hand Welltower has an analysts' consensus of $165.05 which suggests that it could grow by 15.69%. Given that Welltower has higher upside potential than National Health Investors, analysts believe Welltower is more attractive than National Health Investors.

National Health Investors has a beta of 0.788, which suggesting that the stock is 21.162% less volatile than S&P 500. In comparison Welltower has a beta of 0.932, suggesting its less volatile than the S&P 500 by 6.829%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.94%. Welltower offers a yield of 1.84% to investors and pays a quarterly dividend of $0.67 per share. National Health Investors pays 113.43% of its earnings as a dividend. Welltower pays out 162.37% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Welltower quarterly revenues of $2.2B. National Health Investors's net income of $43.2M is lower than Welltower's net income of $120M. Notably, National Health Investors's price-to-earnings ratio is 23.34x while Welltower's PE ratio is 91.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.58x versus 11.06x for Welltower. Usually stocks with elevated PS ratios are considered overvalued.